跳至主要内容
临床试验/NCT02303808
NCT02303808已完成不适用

Effect of Introducing a Positive Expiratory Pressure Device During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis: a Randomized Crossover Trial.

Universidad San Jorge1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Wet sputum production

研究概览

简要总结

This trial aims to analyze whether the inhalation of hypertonic saline combined with a positive expiratory pressure (PEP) device increases the amount of sputum expectorated during the chest physiotherapy session ( inhalation + bronchial drainage).

详细描述

All patients will perform two different arms of treatment in a crossover randomization. Each arm of treatment will be applied during 5 consecutive days. The wash-out period will be one week. Before starting the trial all patients will do an inhalation formation.

During the study period the patients' pharmacological treatment remains unchanged

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Pass the inhalation test
  • •Chronic sputum production, at least ≥ 10 ml /24h
  • •Cystic Fibrosis (CF) diagnosed ( established by genotype or sweat sodium>70 mmol/l or sweat chloride of>60 mmol/l)
  • •Clinically stable at the time of recruitment (defined as no requirement for antibiotics or change in respiratory medication in the preceding 4 weeks)
  • •Trained in the use of autogenic drainage technique (at least 6 months)
  • •Inhaling hypertonic saline since at least 6 months
  • •To be able to provide written, informed consent and perform the protocol and the evaluations

排除标准

  • •Active massive hemoptysis during the previous 2 months
  • •Patient in transplantation or retransplantation list
  • •Patient already participating in another study at the same time

研究组 & 干预措施

USUAL CARE

No Intervention

Patients will perform the inhalation of the 7% hypertonic saline (following the gold standard recomendation) during 15 minutes. Right after, patients will perform independently their usual session of autogenic drainage during 30 minutes.

INHALATION WITH PEP DEVICE

Active Comparator

Patients will perform the inhalation of the 7% hypertonic saline (following the gold standard recomendation) combined with a PEP device (Acapella Duet) during 15 minutes. Right after, patients will perform independently their usual session of autogenic drainage during 30 minutes.

干预措施: INHALATION WITH PEP DEVICE (Acapella Duet) (Device)

结局指标

主要结局

Wet sputum production

时间窗: 45 minutes

Wet sputum production (ml) during chest physiotherapy session (inhalation + bronchial drainage)

次要结局

  • Lung function (simply spirometry)(5 days)
  • Patient's perception (Likert test)(5 days)
  • Questionnaire(5 days)
  • Wet sputum production(22 hours)
  • Safety and tolerability of session (Pulse-oximetry, heart rate, dyspnea, hemoptysis, cough, throat irritability and saltiness, heart rate)(45 minutes)
  • Wet sputum production(2 hours)

研究者

发起方
Universidad San Jorge
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验